Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury
Naga Chalasani, Yi‐Ju Li, Andrew Dellinger, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 293-300
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts
Palak Trivedi, Gideon M. Hirschfield, David H. Adams, et al.
Gastroenterology (2024) Vol. 166, Iss. 6, pp. 995-1019
Closed Access | Times Cited: 22
Analysis of Immunometabolic Profiles in Patients With Chronic Drug‐Induced Liver Injury and Validation in Mice to Reveal Potential Mechanisms
Xingran Zhai, Xian He, Ang Huang, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 1
Drug Induced Liver Injury: Highlights and Controversies in the 2023 Literature
Harjit Singh, Bryce Kunkle, Angela Troia, et al.
Drug Safety (2025)
Closed Access | Times Cited: 1
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries
Miren García‐Cortés, Aida Ortega‐Alonso, Gonzalo Matilla‐Cabello, et al.
Liver International (2023) Vol. 43, Iss. 8, pp. 1749-1760
Open Access | Times Cited: 17
Clinical characteristics and HLA associations of azithromycin‐induced liver injury
Caroline Conlon, Yi‐Ju Li, Jawad Ahmad, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 6, pp. 787-795
Open Access | Times Cited: 8
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative
Eric Cohen, Meenal Patwardhan, Ritu Raheja, et al.
Drug Safety (2024) Vol. 47, Iss. 4, pp. 301-319
Open Access | Times Cited: 7
Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use
Rolf Teschke, Gaby Danan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10855-10855
Open Access | Times Cited: 14
Recent advances in the diagnosis of drug-induced liver injury
Taqwa Ahmed, Jawad Ahmad
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 186-192
Open Access | Times Cited: 5
Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method
Rolf Teschke, Gaby Danan
Medicines (2024) Vol. 11, Iss. 4, pp. 9-9
Open Access | Times Cited: 4
Defining characteristics and long‐term prognosis of drug‐induced autoimmune‐like hepatitis: A retrospective cohort study
Yooyun Chung, Maura Morrison, Yoh Zen, et al.
United European Gastroenterology Journal (2023) Vol. 12, Iss. 1, pp. 66-75
Open Access | Times Cited: 10
Molecular docking to investigate HLA-associated idiosyncratic drug reactions
Kejun Li, Volker M. Lauschke, Yitian Zhou
Drug Metabolism Reviews (2025), pp. 1-34
Open Access
Drug‐Induced Liver Injury in Patients With Chronic Liver Disease
Marwan Ghabril, Raj Vuppalanchi, Naga Chalasani
Liver International (2025) Vol. 45, Iss. 3
Open Access
Risk factors and prediction for DILI in clinical practice
Helgi K. Björnsson, Einar S. Björnsson
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access
Drug-Induced Liver Injury—Pharmacological Spectrum Among Children
Bianca Raluca Maris, Alina Grama, Tudor Lucian Pop
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2006-2006
Open Access
Clinical Considerations of Drug-Induced Hepatotoxicity
Melanie Hundt, Mahmoud Galal Moawad Mohamed, Lily Dara
Elsevier eBooks (2025)
Closed Access
Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors
Camilla Stephens, M. Isabel Lucena, Raúl J. Andrade
Elsevier eBooks (2025)
Closed Access
Natural History of Idiosyncratic Drug‐Induced Liver Injury and Prognostic Models
Harshad Devarbhavi, Raúl J. Andrade
Liver International (2025) Vol. 45, Iss. 6
Open Access
Drug-induced liver injury due to nitrofurantoin: Similar clinical features, but different HLA risk alleles in an independent cohort
Ann K. Daly, Einar S. Björnsson, M. Isabel Lucena, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 5, pp. e165-e166
Open Access | Times Cited: 14
Idiosyncratic DILI and RUCAM under One Hat: The Global View
Rolf Teschke, Gaby Danan
Livers (2023) Vol. 3, Iss. 3, pp. 397-433
Open Access | Times Cited: 7
The clinical application of genetic testing in DILI, are we there yet?
Matthew S. Krantz, Madeline Marks, Elizabeth J. Phillips
Clinical Liver Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
A 68-Year-Old Woman With Unexplained Liver Enzyme Elevation and Active Chronic Hepatitis: Beware of Drug-Induced Autoimmune-Like Hepatitis
Lily Dara, Marwan Ghabril, Elizabeth Phillips, et al.
Gastroenterology (2023) Vol. 166, Iss. 2, pp. 259-266.e1
Open Access | Times Cited: 4
Review of human risk factors for idiosyncratic drug-induced liver injury: latest advances and future goals
Helgi K. Björnsson, Einar S. Björnsson
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 12, pp. 969-977
Closed Access | Times Cited: 4
Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment
Jiayi Ma, Einar S. Björnsson, Naga Chalasani
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 239-257
Closed Access | Times Cited: 1
Genetic and Genomic Approaches to the Study of Drug‐Induced Liver Injury
Ann K. Daly
Liver International (2024) Vol. 45, Iss. 1
Open Access | Times Cited: 1
Relevance of Pharmacogenomics to the Safe Use of Antimicrobials
Ann K. Daly
Antibiotics (2023) Vol. 12, Iss. 3, pp. 425-425
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top